Jiangsu Lintex Advanced Materials
920106
Beijing Chieftain Control Technology Group
300430
Jiangsu Apon Medical Technology
300753
Fujian Zitian Media Technology
300280
SigmaStar Technology
301536
CN Stock MarketDetailed Quotes
688580 Nanjing Vishee Medical Technology Co., Ltd
- 33.19
- +2.09+6.72%
Market Closed Dec 18 15:00 CST
3.18BMarket Cap28.20P/E (TTM)
33.39High29.90Low27.20KlotVolume30.90Open31.10Pre Close87.06MTurnover2.84%Turnover Ratio23.32P/E (Static)95.77MShares45.1152wk High1.97P/B3.18BFloat Cap20.2652wk Low37.32Limit Up95.77MShs Float166.58Historical High24.88Limit Down11.22%Amplitude20.26Historical Low1.08Dividend TTM32.01Avg Price13.41KlotAsk3.25%Div YieldTTM100Lot Size12.58KlotBid
Nanjing Vishee Medical Technology Co., Ltd Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -12.06%291.76M | -12.84%191.58M | -8.24%87.67M | 43.72%462.22M | 53.19%331.77M | 63.87%219.8M | 76.57%95.54M | -25.21%321.62M | -28.60%216.58M | -29.94%134.13M |
| Operating revenue | -12.06%291.76M | -12.84%191.58M | -8.24%87.67M | 43.72%462.22M | 53.19%331.77M | 63.87%219.8M | 76.57%95.54M | -25.21%321.62M | -28.60%216.58M | -29.94%134.13M |
| Total operating cost | -5.80%231.83M | -1.88%154.66M | 1.60%72.38M | 40.48%347.04M | 41.75%246.11M | 40.88%157.63M | 46.10%71.24M | -10.79%247.04M | -17.11%173.62M | -14.86%111.89M |
| Operating cost | -11.01%84.37M | -10.50%56.3M | -4.35%26.14M | 47.45%130.51M | 64.45%94.8M | 78.78%62.9M | 98.56%27.33M | -18.38%88.52M | -25.85%57.65M | -30.56%35.19M |
| Operating tax surcharges | -1.09%3.97M | -5.84%2.64M | -0.62%1.28M | 43.77%5.73M | 53.65%4.02M | 75.82%2.8M | 115.12%1.29M | -26.74%3.98M | -30.18%2.61M | -30.05%1.59M |
| Operating expense | -10.80%78.09M | -11.76%50.3M | -14.05%22.22M | 35.07%123.64M | 41.87%87.55M | 50.85%57M | 71.77%25.85M | 17.21%91.54M | -5.11%61.71M | -6.29%37.79M |
| Administration expense | 1.64%33.64M | 24.42%24.14M | 31.75%12.72M | 24.42%47.49M | 14.67%33.09M | 2.36%19.4M | -2.58%9.66M | 0.50%38.17M | 1.94%28.86M | 6.87%18.96M |
| Financial expense | 45.76%-8.17M | 26.81%-7.45M | -16.90%-5.41M | 4.88%-17.98M | -8.91%-15.05M | -31.74%-10.18M | -32.47%-4.63M | -14.06%-18.9M | -16.87%-13.82M | -0.19%-7.73M |
| -Interest expense (Financial expense) | -3.83%965.57K | 1.78%643.72K | -1.59%321.86K | 294.72%1.32M | 888.64%1M | 774.78%632.48K | 804.68%327.05K | 80.86%334.05K | -28.39%101.56K | -26.92%72.3K |
| -Interest Income (Financial expense) | 43.08%-9.15M | 25.12%-8.11M | -15.75%-5.71M | -0.18%-19.32M | -15.20%-16.07M | -38.62%-10.84M | -39.45%-4.93M | -14.77%-19.28M | -16.23%-13.95M | 0.24%-7.82M |
| Research and development | -4.26%39.93M | 11.80%28.73M | 31.42%15.43M | 31.83%57.65M | 13.91%41.71M | -1.51%25.7M | -9.18%11.74M | -31.15%43.73M | -21.20%36.61M | -7.21%26.09M |
| Credit Impairment Loss | 49.37%-133.33K | -146.10%-139.75K | -117.72%-11.29K | -222.02%-2.19M | -182,901.57%-263.36K | -158.16%-56.78K | -79.99%63.7K | 23.72%-679.57K | 99.98%-143.91 | 113.05%97.63K |
| Other net revenue | ||||||||||
| Fair value change income | ---- | ---- | ---- | ---964.05K | ---- | ---- | ---- | ---- | ---- | ---- |
| Invest income | 15.34%8.24M | -0.68%5M | -64.96%1.13M | -33.92%10.58M | -46.16%7.14M | -50.94%5.04M | -39.20%3.24M | -22.11%16.01M | -16.89%13.27M | 2.33%10.27M |
| Asset deal income | -88.60%434.96 | -88.60%434.96 | ---- | ---2.11K | --3.81K | --3.81K | --3.81K | ---- | ---- | ---- |
| Other revenue | -14.01%16.33M | 14.07%11.07M | 33.57%6.21M | 77.68%25.83M | 87.79%18.99M | 37.26%9.71M | -5.89%4.65M | -33.57%14.54M | -3.71%10.11M | 5.08%7.07M |
| Operating profit | -24.36%84.36M | -31.23%52.86M | -29.86%22.62M | 42.11%148.44M | 68.13%111.53M | 93.72%76.86M | 102.49%32.26M | -46.34%104.46M | -44.43%66.34M | -47.81%39.68M |
| Add:Non operating Income | -79.33%143.81K | -82.41%118.01K | -84.06%102.05K | 12.86%1.61M | -36.43%695.78K | -37.92%671.06K | -70.16%640.13K | -48.08%1.43M | -53.60%1.09M | -51.39%1.08M |
| Less:Non operating expense | -36.96%28.53K | -36.73%28.53K | ---- | -4.69%42.29K | 1,324.51%45.25K | 1,319.34%45.09K | 897.30%31.68K | -9.88%44.37K | -92.85%3.18K | -86.99%3.18K |
| Total profit | -24.70%84.48M | -31.67%52.95M | -30.85%22.73M | 41.73%150.01M | 66.37%112.19M | 90.13%77.49M | 81.86%32.86M | -46.38%105.84M | -44.59%67.43M | -47.90%40.75M |
| Less:Income tax cost | -39.94%6.31M | -51.99%3.33M | -65.05%972.31K | 14.47%13.75M | 99.62%10.5M | 177.49%6.93M | 162.12%2.78M | -39.46%12.01M | -63.41%5.26M | -72.97%2.5M |
| Net profit | -23.13%78.17M | -29.67%49.62M | -27.69%21.75M | 45.22%136.26M | 63.56%101.68M | 84.43%70.56M | 76.85%30.08M | -47.15%93.83M | -42.06%62.17M | -44.54%38.26M |
| Net profit from continuing operation | -23.13%78.17M | -29.67%49.62M | -27.69%21.75M | 45.22%136.26M | 63.56%101.68M | 84.43%70.56M | 76.85%30.08M | -47.15%93.83M | -42.06%62.17M | -44.54%38.26M |
| Net profit of parent company owners | -23.13%78.17M | -29.67%49.62M | -27.69%21.75M | 45.22%136.26M | 63.56%101.68M | 84.43%70.56M | 76.85%30.08M | -47.23%93.83M | -42.21%62.17M | -44.70%38.26M |
| Earning per share | ||||||||||
| Basic earning per share | -22.88%0.8221 | -29.48%0.5216 | -27.46%0.3196 | 45.35%1.9969 | 17.12%1.066 | 32.05%0.7396 | 77.02%0.4406 | -47.19%1.3739 | -42.17%0.9102 | -44.67%0.5601 |
| Diluted earning per share | -22.97%0.8205 | -29.65%0.5202 | -27.60%0.319 | 45.20%1.9938 | 17.29%1.0652 | 32.27%0.7394 | 77.59%0.4406 | -47.07%1.3731 | -41.99%0.9082 | -44.54%0.559 |
| Other composite income | ||||||||||
| Total composite income | -23.13%78.17M | -29.67%49.62M | -27.69%21.75M | 45.22%136.26M | 63.56%101.68M | 84.43%70.56M | 76.85%30.08M | -47.15%93.83M | -42.06%62.17M | -44.54%38.26M |
| Total composite income of parent company owners | -23.13%78.17M | -29.67%49.62M | -27.69%21.75M | 45.22%136.26M | 63.56%101.68M | 84.43%70.56M | 76.85%30.08M | -47.23%93.83M | -42.21%62.17M | -44.70%38.26M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
